Cargando…
Growth and Migration Blocking Effect of Nanaomycin K, a Compound Produced by Streptomyces sp., on Prostate Cancer Cell Lines In Vitro and In Vivo
SIMPLE SUMMARY: Recent molecularly targeted drugs used to treat castration-resistant prostate cancer (CRPC) soon lose effectiveness as CRPC develops resistance to these therapeutics. New molecularly targeted drugs for effective treatment of CRPC are needed. In this study, we investigated the antican...
Autores principales: | Hirata, Yuto, Shigemura, Katsumi, Moriwaki, Michika, Iwatsuki, Masato, Kan, Yuki, Ooya, Tooru, Maeda, Koki, Yang, Youngmin, Nakashima, Takuji, Matsuo, Hirotaka, Nakanishi, Jun, Fujisawa, Masato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216623/ https://www.ncbi.nlm.nih.gov/pubmed/37345021 http://dx.doi.org/10.3390/cancers15102684 |
Ejemplares similares
-
Nanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivo
por: Kitagawa, Koichi, et al.
Publicado: (2021) -
Combined Treatment with Ultrasound and Immune Checkpoint Inhibitors for Prostate Cancer
por: Hayashi, Fuuka, et al.
Publicado: (2022) -
Relevance of A Disintegrin and Metalloproteinase Domain-Containing (ADAM)9 Protein Expression to Bladder Cancer Malignancy
por: Moriwaki, Michika, et al.
Publicado: (2022) -
A case of refractory urethritis with repeated doctor shopping
por: Maeda, Koki, et al.
Publicado: (2022) -
What are the differences between older and younger patients with epididymitis?
por: Yamamichi, Fukashi, et al.
Publicado: (2017)